The Cost-Effectiveness and Budget Impact of Ibalizumab-uiyk for Adults with Multidrug-Resistant HIV-1 Infection in the United States.
Pharmacoeconomics
; 39(4): 421-432, 2021 04.
Article
in En
| MEDLINE
| ID: mdl-33532919
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
HIV Infections
/
HIV-1
Type of study:
Health_economic_evaluation
Limits:
Adult
/
Humans
Country/Region as subject:
America do norte
Language:
En
Journal:
Pharmacoeconomics
Journal subject:
FARMACOLOGIA
/
TERAPIA POR MEDICAMENTOS
Year:
2021
Document type:
Article
Affiliation country:
United States